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Telomeric G-quadruplexes are a substrate and site
of localization for human telomerase
Aaron L. Moye1,*, Karina C. Porter1,*, Scott B. Cohen1,*, Tram Phan2, Katherine G. Zyner1, Natsuki Sasaki1,
George O. Lovrecz2, Jennifer L. Beck3 & Tracy M. Bryan1
It has been hypothesized that G-quadruplexes can sequester the 30 end of the telomere and
prevent it from being extended by telomerase. Here we purify and characterize stable,
conformationally homogenous human telomeric G-quadruplexes, and demonstrate that
human telomerase is able to extend parallel, intermolecular conformations in vitro. These
G-quadruplexes align correctly with the RNA template of telomerase, demonstrating that at
least partial G-quadruplex resolution is required. A highly purified preparation of human
telomerase retains this extension ability, establishing that the core telomerase enzyme
complex is sufficient for partial G-quadruplex resolution and extension. The parallel-specific
G-quadruplex ligand N-methyl mesoporphyrin IX (NMM) causes an increase in telomeric
G-quadruplexes, and we show that telomerase colocalizes with a subset of telomeric
G-quadruplexes in vivo. The ability of telomerase to partially unwind, extend and localize to
these structures implies that parallel telomeric G-quadruplexes may play an important
biological role.
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H
uman chromosomes terminate with B5–10 kb of the
telomeric DNA repeat TTAGGG1,2. The shortening of
telomeres to a critical length is a signal for cellular
senescence3,4. Telomere shortening is counteracted by telomerase,
the telomere-specific reverse transcriptase that contains an
RNA template to direct the addition of telomeric DNA by the
catalytic telomerase reverse transcriptase (TERT) component5–7.
Telomerase is upregulated in Z85% of tumours, providing a
telomere maintenance mechanism that contributes to cellular
immortalization and tumour progression8,9.
Telomeric DNA can fold into compact G-quadruplex
structures involving the interaction of four guanine bases in a
square planar arrangement stabilized by central cations10.
G-quadruplexes can form from one, two or four strands of
DNA in a parallel or antiparallel orientation11. Over 375,000
sequences with the potential to form G-quadruplexes have been
identified within the human genome12. There is increasing
evidence supporting in vivo functions for DNA and RNA
G-quadruplexes, including telomere protection and involvement
in transcription, translation and splicing13–16. Direct evidence for
the existence of G-quadruplexes at telomeres was obtained using
specific antibodies against G-quadruplexes in the telomeric DNA
of the ciliate Stylonychia lemnae17. Recently, a G-quadruplex-
specific antibody has also been used to directly visualize
G-quadruplexes throughout the human genome, a portion of
which is located at telomeres18. There are a large number of
small-molecule ligands that have specificity for G-quadruplexes,
with many of them causing telomere dysfunction in vivo and
inhibiting telomerase activity in vitro19–21.
The first report describing the inability of telomerase to extend
G-quadruplexes, using the ciliate Oxytricha nova, did not
differentiate between specific conformations as substrates22. In
2006, we demonstrated using purified G-quadruplex structures
that some conformations can be extended by telomerase from the
ciliated protozoa Tetrahymena thermophila and Euplotes
aediculatus: parallel-stranded intermolecular G-quadruplexes
were substrates for ciliate telomerase, whereas antiparallel
intramolecular G-quadruplexes were not23. Telomere biology is
very different between ciliated protozoa and humans, and the
telomerase ribonucleoproteins from the two groups differ in key
properties such as the ability to extend non-telomeric DNA,
the mechanism of template boundary definition and the
components and multimeric state of the enzyme complex24–28.
The possibility therefore existed that the ability to extend parallel
G-quadruplexes is a ciliate-specific property of telomerase. Given
the intense interest in telomerase inhibition by G-quadruplex
stabilizers as a potential cancer therapeutic20,21, and the
polymorphism of human telomeric G-quadruplexes11, we
considered it important to determine the ability of human
telomerase to extend defined conformations of G-quadruplex.
In this study, we establish that the ability to extend
parallel intermolecular G-quadruplexes is conserved among
evolutionarily distant species. We characterize purified, stable,
conformationally homogenous human telomeric G-quadruplexes
and demonstrate that human telomerase is able to recognize
and partially unwind parallel intermolecular conformations and
extend the unwound 30 end in vitro. Treatment of immortal
human cells with the parallel-specific G-quadruplex ligand
N-methyl mesoporphyrin IX results in a significant increase in
G-quadruplexes present at telomeres in vivo, indicating the
potential for formation of a parallel G-quadruplex structure at
human telomeres. We show that human telomerase localizes to a
subset of telomeres that contain G-quadruplexes in vivo.
Results
Folding and characterization of parallel G-quadruplexes.
To test the ability of human telomerase to extend G-quadruplex
DNA, we isolated and characterized parallel, intermolecular
G-quadruplexes, since this is the conformation extended by
ciliate telomerase23. To be certain that telomerase extends the
G-quadruplex rather than its unfolded linear counterpart, it is
necessary to work with structures with very slow unfolding rates
under the conditions of a telomerase activity assay (30 C, 1 h).
Human telomeres have one less contiguous guanine residue
than their ciliate counterparts (TTAGGG versus TTGGGG),
which renders the corresponding G-quadruplexes less stable29.
It is possible, however, to form stable human telomeric
G-quadruplexes using cations such as Sr2þ , rather than Kþ or
Naþ (refs 30,31). Tetramolecular G-quadruplexes formed from
short oligonucleotides also tend to be relatively stable29,32.
The oligonucleotide 7GGT (Table 1) formed a tetrameric
G-quadruplex, [7GGT]4, when annealed in buffer containing
150 mM KCl, and gave a single band upon native gel
electrophoresis. This band was purified from the native gel and
remained 498% pure after purification (Fig. 1a). The circular
dichroism (CD) spectrum of [7GGT]4 gave a positive signal at
260 nm and a negative signal at 240 nm, characteristic of a parallel
G-quadruplex (Fig. 1b)33. The ultraviolet thermal difference
spectrum (TDS)34 of [7GGT]4 showed a negative peak at
295 nm (Supplementary Fig. 1a), supporting the assignment of
a G-quadruplex structure29,32.
The oligonucleotide 22GGG (Table 1) gave rise to two bands
on a native gel when annealed in 2.5 mM Sr2þ (Fig. 1c). The
migration of the upper and lower bands was consistent with
formation of intermolecular and intramolecular structures,
respectively10. Each G-quadruplex band remained Z95% pure
after gel purification (Fig. 1c); no linear 22GGG was observed
after purification. CD analysis of the upper band was indicative of
a parallel G-quadruplex structure (Fig. 1d), whereas the lower
band gave a maximum absorbance at 295 nm and a minimum at
260 nm, consistent with an antiparallel structure (Fig. 1d). The
TDS spectra for both the upper and lower bands of 22GGG
confirmed G-quadruplex structures (Supplementary Fig. 1b,c).
Electrospray ionization mass spectrometry (ESI-MS) was used
to determine G-quadruplex stoichiometry35,36. The purified
22GGG lower band gave predominant ions that were assigned
to unimolecular species, consistent with the inclusion of an
Table 1 | Oligonucleotides used and G-quadruplex structures characterized in this study.
Nomenclature Sequence (50–30) Length
(nt)
G4
nomenclature
Annealing
cation
Strand
orientation
Strand
stoichiometry
T½
(C)
7GGT TTAGGGT 7 [7GGT]4 150 mM K
þ Parallel Tetramer 68
22GGG AGGG(TTAGGG)3 22 [22GGG]2 2.5 mM Sr
2þ Parallel Dimer 490
22GGG AGGG(TTAGGG)3 22 [22GGG]1 2.5 mM Sr
2þ Antiparallel Intramolecular 68
9C CCCTAACCC 9
T15 TTTTTTTTTTTTTTT 15
T25 TTTTTTTTTTTTTTTTTTTTTTTTT 25
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Sr2þ ion within an intramolecular G-quadruplex (Fig. 1e;
Supplementary Table 1). A lower-abundance ion can be
assigned as the dimeric G-quadruplex species [2Mþ 3Sr2þ -
13H]7 (where M is neutral, unimolecular 22GGG), consistent
with the observation of some reformation of the upper parallel
G-quadruplex after purification. Together, the migration pattern
on native gel electrophoresis, ESI-MS and CD analysis indicate
that the lower band of 22GGG annealed in Sr2þ is an
intramolecular antiparallel G-quadruplex, which will henceforth
be referred to as [22GGG]1.
The predominant ions observed from the purified upper band
of 22GGG represented bimolecular DNA along with a unim-
olecular G-quadruplex (Fig. 1f; Supplementary Table 1); this is
consistent with the observation of some upper band converting to
the intramolecular G-quadruplex after purification. The ESI mass
spectrum, combined with CD and TDS analysis and native gel
electrophoresis, is consistent with a parallel, dimeric G-quad-
ruplex, here called [22GGG]2.
Absence of spontaneous unfolding of G-quadruplexes. The
relative stabilities of the purified G-quadruplexes were initially
assessed by determining their melting temperatures. Since inter-
molecular G-quadruplexes reform very slowly and are therefore
not at equilibrium during the measurement, we refer to this
value as T½ rather than Tm, which is the true thermodynamic
parameter at equilibrium29. The ultraviolet melting curve of
[7GGT]4 gave a T½ of 68 C (measured at a heating rate of
1 C min 1; Supplementary Fig. 1d; Table 1).
To determine the amount of [7GGT]4 that unfolds during the
course of a telomerase activity assay (30 C, 1 h), we employed a
complementary C-strand trap assay. A 10-fold excess of C-rich
complementary strand (Table 1) was added to the G-quadruplex
in the same buffer used for telomerase activity assays (described
below), and the extent of Watson–Crick duplex formation was
monitored over 4 h by non-denaturing gel electrophoresis37,38
(Fig. 2a). Control experiments established that the result was
unaffected by increasing C-strand concentrations, up to 100-fold
over G-quadruplex (Supplementary Fig. 2a), demonstrating that
the rate of Watson–Crick duplex formation reflects the rate of
G-quadruplex unfolding. After 1 h at 30 C, B1% of the
G-quadruplex had hybridized to the complementary strand,
with B3–4% hybridized after 4 h (Fig. 2a,b). As a further test of
the stability of [7GGT]4, the G-quadruplex was treated with
phosphodiesterase 1 (P1), which cleaves single-stranded DNA
exonucleolytically at the 30 end. Under conditions identical to the
telomerase activity assays below (30 C for 1 h), all of the
P1-treated linear 7GGT was digested while no [7GGT]4 digestion
was detected (Fig. 2c). The 7-nt oligonucleotide remained intact
after digestion, demonstrating that even the single thymidine at
the 30 end of each of the four strands is participating in tertiary
structure and being protected from digestion. Overall, these data
demonstrate that the G-quadruplex [7GGT]4 is stable under the
conditions of the telomerase activity assay.
The T½ values of [22GGG]2 and [2GGG]1 were 490
and 68 C, respectively, when measured at 1 C min 1
(Supplementary Fig. 1e,f; Table 1). The high melting temperature
of the dimeric species indicates that it is an exceptionally stable
structure. An identical complementary C-strand experiment was
performed with [22GGG]2 in 2.5 mM Sr2þ buffer. After 4 h at
30 C, there was no observable duplex formation, indicating that
the [22GGG]2 G-quadruplex does not unfold under our assay
conditions (Fig. 2d). This was confirmed by digestion with P1 at
30 C for 1 h; no digestion of [22GGG]2 was observed (Fig. 2e,f,
right lanes). It should be noted that any [22GGG]2 that did unfold
over days or weeks in storage rapidly formed [22GGG]1, with no
linear 22GGG oligonucleotide observed (Fig. 1c).
Intramolecular G-quadruplexes often display rapid folding and
unfolding rates23,39. Under the conditions used in this study,
it was not possible to obtain a native gel or CD spectrum that
corresponded to linear, unfolded 22GGG in the presence of
2.5 mM SrCl2. When incubated with P1, only B30% of ‘linear’
22GGG in 2.5 mM SrCl2 was digested (Fig. 2e,f, middle lanes).
This suggests that linear 22GGG in the presence of Sr2þ is in
rapid equilibrium with [22GGG]1. To confirm this, we ‘locked’
linear 22GGG into an unfolded conformation by pre-binding it
with the 9C complementary oligonucleotide (Supplementary
Fig. 2b), as previously described39. After digestion with P1, only
10% of the DNA remained undigested (Fig. 2e,f, left lanes). These
data demonstrate that the P1 exonuclease was functional in this
experiment, and that linear 22GGG and intramolecular
[22GGG]1 G-quadruplex are in rapid equilibrium when in the
presence of 2.5 mM Sr2þ .
Parallel G-quadruplexes are substrates of human telomerase.
Telomerase activity assays were performed with the
G-quadruplexes characterized above to determine whether par-
allel, intermolecular G-quadruplexes are a substrate for human
telomerase. Telomerase was prepared by overexpressing its
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Figure 1 | Characterization of gel-purified telomeric G-quadruplexes.
(a) Native gel electrophoresis of purified 32P-labelled [7GGT]4 in 150 mM
Kþ . Lane 1: [7GGT]4 after gel purification. Lane 2: unfolded 7GGT. Lanes
3 and 4: T25 and T15 unstructured molecular weight (MW) markers.
(b) CD spectrum of gel-purified [7GGT]4 in 150 mM K
þ . (c) Native gel
electrophoresis of G-quadruplexes formed from 22GGG in 2.5 mM Sr2þ ,
stained in SYBR Gold. Lane 1: unpurified folded 22GGG. Lane 2: post-
purification folded 22GGG upper band, [22GGG]2. Lane 3: post-purification
22GGG lower band, [22GGG]1. Lanes 4 and 5: unstructured MW markers
T25 and T15. (d) CD spectra of gel-purified 22GGG G-quadruplexes in
2.5 mM Sr2þ . (e) Negative ion ESI mass spectra of the lower band of
folded 22GGG and (f) the upper band of folded 22GGG. K [M-5H]5 ;
B [M-4H]4 ; J [Mþ Sr2þ -7H]5 ; ~ [Mþ Sr2þ -6H]4 ;
’ [2Mþ 3Sr2þ -13H]7 ; & [2Mþ 3Sr2þ -14H]8 .
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components in 293T cells40 and immunopurifying the assembled
complex with an hTERT antibody41. The G-quadruplex [7GGT]4
was readily extended by human telomerase (Fig. 3a): the
Michaelis–Menton constant (Km) for 7GGT was 100±20 nM
and that for [7GGT]4 was 500±120 nM (mean±s.d.; n¼ 4–6).
Notably, both substrates supported equal amounts of catalytic
activity, with a relative Vmax (folded/linear) of 0.97±0.07
(mean±s.d.; P¼ 0.3, one-sample t-test; n¼ 7).
There is a possibility that the one-step telomerase immuno-
purification method used in these experiments could allow
co-immunopurification of other proteins that may selectively
unwind the parallel G-quadruplexes, allowing the observed
extension. To exclude this possibility, we purified human
telomerase further with a four-step procedure involving
immunopurification, capture onto an immobilized telomeric
DNA substrate, release of active enzyme and sedimentation over
a glycerol gradient42 (Fig. 3b); the specific activity of telomerase on
an 18-nt telomeric substrate does not change over the course of
purification (Supplementary Fig. 3). The purity of this telomerase
was confirmed on a silver-stained SDS–polyacrylamide gel
electrophoresis (PAGE) gel (Fig. 3b); the only visible protein
bands correspond to the sizes of the core telomerase components
hTERT and dyskerin42. The G-quadruplex helicase DHX36 (also
known as G4R1 or RHAU) has been shown to associate with a
portion of active telomerase in immortal human cells43,44;
we confirmed this association in our 293T system by
immunoblot analysis for DHX36 on one-step immunopurified
telomerase (Fig. 3c). However, our four-step purification procedure
resulted in loss of DHX36, confirmed by immunoblot of an equal
molar amount of highly purified telomerase (GG in Fig. 3c).
Telomerase activity assays were performed with this
highly purified telomerase alongside one-step immunopurified
telomerase. The relative activity using [7GGT]4 G-quadruplex
and 7GGT linear DNA as substrates was the same for highly
purified as for one-step purified telomerase (Fig. 3d). This
confirms that the core telomerase enzyme complex is sufficient
for extension of [7GGT]4.
The dimeric parallel G-quadruplex [22GGG]2 was also readily
extended by immunopurified human telomerase, with a Km of
53±10 nM (Fig. 4a; mean±s.d.; n¼ 4), under conditions in
which we had demonstrated that this G-quadruplex is extremely
stable. [22GGG]2 was also extended by the highly purified
telomerase preparation (Fig. 4b). Thus, the core human
telomerase complex is capable of extending multiple parallel,
intermolecular G-quadruplexes.
Obtaining reproducibly quantitative telomerase activity assays
for linear 22GGG and [22GGG]1 was confounded by the rapid
interconversion between the folded and unfolded forms. It is well
established that intramolecular, antiparallel G-quadruplexes are
not good substrates for either ciliate or human telomerase22,23,39.
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Figure 2 | Stability of telomeric G-quadruplexes. (a) [7GGT]4 complementary strand trap assay: 5
0-end-labelled [7GGT]4 in 150 mM K
þ , incubated with
10-fold excess complementary strand 9C at 30 C and electrophoresed on a 12% non-denaturing polyacrylamide gel. Lane 1: unstructured molecular weight
(MW) marker T15. Lane 2: denatured 7GGT. Lane 3: pre-annealed Watson–Crick (WC) duplex. Lane 4: gel-purified [7GGT]4 G-quadruplex. Lanes 5–11:
[7GGT]4 incubated with 9C at 30 C for the indicated times. Lane 12: [7GGT]4. Lane 13: pre-annealed WC duplex. Samples were loaded at the times
indicated, with the gel running between loadings, so later samples underwent shorter electrophoresis times. The last three lanes were loaded
simultaneously. (b) Proportion of [7GGT]4 remaining over time at 30 C. Error bars represent s.d. of the mean of three independent experiments.
(c) P1 digestion of 7GGT and [7GGT]4 electrophoresed on a 12% denaturing polyacrylamide gel; digestions were performed in triplicate. Control lane:
end-labelled 7GGT. (d) [22GGG]2 complementary strand trap assay. Unlabelled [22GGG]2 in 2.5 mM Sr
2þ , incubated with 10-fold excess complementary
strand 9C at 30 C, electrophoresed on a 16% non-denaturing polyacrylamide gel and stained in SYBR Gold. Lane 1: unstructured MW marker T25. Lane 2:
pre-annealed WC duplex. Lane 3: gel-purified [22GGG]2. Lanes 4–11: G-quadruplex [22GGG]2 incubated with 9C at 30 C for the indicated times. Lane 12:
gel-purified [22GGG]2. (e) P1 digestion of 22GGG hybridized to complementary strand 9C, linear 22GGG and [22GGG]2, electrophoresed on a 12%
denaturing polyacrylamide gel; digestions were performed in triplicate. Control lane: end-labelled 22GGG. (f) Data from e, quantified. Error bars represent
s.d. of the mean of triplicates. LC indicates a 32P-labelled 100-nt oligonucleotide used as a control for loading and recovery.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8643
4 NATURE COMMUNICATIONS | 6:7643 | DOI: 10.1038/ncomms8643 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
To confirm that this is also the case for the [22GGG]1
intramolecular G-quadruplex folded in Sr2þ , we again ‘locked’
linear 22GGG in Sr2þ into the unfolded form by hybridizing it
with the complementary DNA oligonucleotide 9C39, which
resulted in a twofold recovery of activity (Fig. 4c,d). In contrast,
addition of the complementary strand to the [22GGG]2
G-quadruplex did not affect activity (Fig. 4c,d). These data
support our hypothesis that unfolded 22GGG is in equilibrium
between linear and antiparallel G-quadruplex conformations,
and confirm that the antiparallel [22GGG]1 G-quadruplex is a
less-favourable substrate for human telomerase than its linear
counterpart. Taken together, these data demonstrate that multiple
parallel, intermolecular G-quadruplexes are substrates for human
telomerase, while an antiparallel, intramolecular G-quadruplex
is not, despite the much higher stability of the former
G-quadruplexes. We have also demonstrated that the core
human telomerase enzyme complex is sufficient for parallel
G-quadruplex extension.
Telomerase partially unwinds parallel G-quadruplexes. We
have demonstrated that, for Tetrahymena telomerase, parallel
G-quadruplex substrates increase the Km of telomerase for the
incoming dTTP nucleotide, presumably by perturbation of the
nucleotide-binding site by the wider G-quadruplex substrate37.
The Km of human telomerase for dTTP was determined in the
presence of saturating [7GGT]4 G-quadruplex and 7GGT linear
DNA at a range of dTTP concentrations (Fig. 5a). The Km of
telomerase for dTTP increased approximately fivefold in the
presence of the G-quadruplex substrate, from 2.8±0.5 mM for
linear 7GGT to 15±5 mM with [7GGT]4 (mean±s.d.; P¼ 0.0136,
unpaired two-tailed t-test; n¼ 3). This change in Km provides
evidence that the observed extension is occurring with two
conformationally distinct substrates.
We demonstrated the maintenance of G-quadruplex structure
following telomerase extension directly, by visualizing telomerase
extension products by native gel electrophoresis. A mixture of
unlabelled [22GGG]1 and [22GGG]2 was extended by telomerase
in the presence of [a-32P]-dTTP (Fig. 5b,c). Under native gel
electrophoresis conditions, a single band was present following
telomerase extension (Fig. 5c, lane 3) that aligns with an authentic
32P-labelled [22GGG]2 marker (Fig. 5c, lane 2). These data
provide evidence that the [22GGG]2 parallel G-quadruplex
structure is maintained following extension by telomerase. Direct
observation of [22GGG]2 specifically labelled through extension
by telomerase provides unequivocal evidence that G-quadruplex
DNA must be the substrate utilized by telomerase.
The telomerase RNA template hybridizes to telomeric DNA
to enable telomere extension with the correct alignment.
Ciliate telomerase can perform extension of non-telomeric
substrates without any complementarity between the DNA
primer and RNA template, using a specific template position as
the default for the initiation of extension26. We wished to test
whether the extension of parallel G-quadruplexes is preceded by
canonical template hybridization (Fig. 5b). We performed
telomerase activity assays in the presence of different
combinations of nucleotides, for both [7GGT]4 and
[22GGG]2 (Fig. 5d,e). A standard processive reaction including
[a-32P]-dGTP, dATP and dTTP provided a marker for band
positions, as the major pause site in a processive reaction
is at the end of the template (products ending in –TAG; see
labelling of gel in Fig. 5d,e). In the presence of only
[a-32P]-dTTP and dATP, we anticipated the addition of two
nucleotides (TA) and three nucleotides (TTA) to primers 7GGT
and 22GGG, respectively, if the terminal 30 nucleotides are
correctly aligning with the RNA template (Fig. 5b). Because
addition of ddGTP results in termination of DNA strand
elongation, we anticipated the addition of three nucleotides
(TAG) and four nucleotides (TTAG) to 7GGT and 22GGG,
respectively, in the presence of [a-32P]-dTTP, dATP and ddGTP.
In all cases, the patterns of extension of parallel G-quadruplexes
[7GGT]4 and [22GGG]2 are identical to their respective linear
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controls (Fig. 5d,e) and correspond with expected nucleotide
addition patterns (Fig. 5b). For canonical hybridization to occur,
at least a portion of the parallel G-quadruplex structure must be
unwound. As native gel electrophoresis demonstrated alignment
of the extended parallel G-quadruplex with an identical
32P-labelled marker (Fig. 5c), we conclude that parallel
G-quadruplexes are partially unwound to allow hybridization of
the telomerase template with the 30 end of the DNA.
Telomerase localizes to G-quadruplex-containing telomeres.
To investigate the presence of parallel telomeric G-quadruplexes
in cells, we performed immunofluorescence on human embryonic
kidney 293T cells using a G-quadruplex-specific antibody18.
Fixed cells were subjected to cytoplasmic extraction prior to
immunofluorescence to remove RNA G-quadruplexes; a DNase-
treated control demonstrates the specificity of the antibody for
DNA G-quadruplexes under these conditions (Fig. 6a, top right).
A subset of telomeres colocalized with G-quadruplex foci (Fig. 6a,
top panel), as previously demonstrated18. Treatment of the
cells with the parallel-specific G-quadruplex porphyrin ligand
N-methyl mesoporphyrin IX45–47 (Supplementary Fig. 4a) during
mid-S phase of the cell cycle resulted in an increase in the number
of G-quadruplex–telomere colocalizations per cell (Fig. 6a,b),
without affecting progression of the cells into mid-S phase
(Supplementary Fig. 4b). These data provide evidence that
parallel G-quadruplexes can form at human telomeres in vivo.
Since human telomerase can extend parallel G-quadruplexes
in vitro, we asked whether telomeric G-quadruplexes are a site of
localization for human telomerase in vivo. 293T cells were
synchronized in mid-S phase, which is the peak of telomerase
recruitment to telomeres48. Using G-quadruplex immuno-
fluorescence, combined with fluorescence in situ hybridization
(FISH) for telomerase RNA (hTR) and telomeres49, we observed
the simultaneous colocalization of endogenous telomerase,
G-quadruplexes and telomeres (Fig. 6c; Supplementary Fig. 5).
Control experiments demonstrate that depletion of dyskerin,
a component of the core telomerase complex42, markedly
reduces hTR foci, verifying the specificity of the FISH signal
(Supplementary Fig. 6). G-quadruplex foci colocalized with
B17% of total hTR-telomere foci (Fig. 6d). These results reveal
that human telomerase can localize to telomeres at which
G-quadruplexes are present.
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Discussion
It has been hypothesized that G-quadruplexes can sequester the 30
end of the telomere and prevent it from being extended by
telomerase22,39. Here, we demonstrate that parallel intermolecular
telomeric G-quadruplexes are partially unwound and robustly
extended by human telomerase. We used highly purified
telomerase to show that the core telomerase enzyme complex
has the ability to partially unwind the G-quadruplexes prior to
their extension.
The apparent affinity of telomerase for the incoming dTTP
nucleotide was significantly reduced when extending [7GGT]4
compared with linear 7GGT, suggesting a change in the
conformation of (or near) the active site of telomerase to
accommodate the wider G-quadruplex structure. This difference
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of Km with different conformations of DNA substrate
demonstrates that the parallel G-quadruplex is a substrate for
telomerase while still at least partially structured, an observation
we confirmed using native gel electrophoresis of a parallel
G-quadruplex following extension (Fig. 5c). Nevertheless, the
telomerase extension patterns demonstrate correct alignment of
the 30 end of the DNA substrate with the RNA template,
indicating that parallel G-quadruplexes are partially unwound by
or invaded by telomerase. Neither of the parallel G-quadruplexes
in this study demonstrated any hybridization to a complementary
DNA oligonucleotide or digestion by a nuclease under the
conditions of the telomerase activity assays, arguing against a
model of spontaneous transient unfolding of the DNA 30 ends
followed by telomerase extension. Given the exceptional stability
of the [22GGG]2 G-quadruplex, in particular, these data support
an extension model where the parallel G-quadruplex structure is
bound and subsequently partially resolved by telomerase prior
to extension of the DNA 30 end (Fig. 7). We are currently
investigating the mechanism of this resolution, including the
regions of telomerase responsible, given that neither hTERT nor
dyskerin contains a known helicase domain. It is possible that
telomerase uses a similar mechanism as that proposed for
replication protein A, involving binding to the single-stranded
loop regions between stacks of G-quartets50.
Currently, there are a large number of laboratories investigat-
ing the interactions of stabilizing ligands with G-quadruplexes.
It is therefore crucial to determine the specificity of human
telomerase for the different conformations of G-quadruplexes,
such that once the in vivo structure(s) of human telomeres
is determined, suitable G-quadruplex-stabilizing ligands of
appropriate specificity can be rationally selected. Although
in vivo evidence for G-quadruplex structures is increasing, the
structure-specific locations and functions of G-quadruplexes
remain speculative. Our in vivo data indicate that parallel
G-quadruplexes can form at human telomeres, and that telomeres
containing a G-quadruplex are a site of localization for human
telomerase. That telomerase is also able to partially unwind and
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extend these structures, and the evolutionary conservation of this
property in distantly related organisms such as Tetrahymena23,
implies that telomeric DNA in a parallel G-quadruplex
conformation may have a biological role. In support of this
idea, it has been demonstrated that promotion of parallel
telomeric G-quadruplexes by the Saccharomyces cerevisiae
protein Est1p is essential for telomerase-mediated telomere
elongation in that organism51. One potential biological role for
telomeric G-quadruplexes in human cells may be during meiosis,
when two pairs of sister chromatids are brought together; it has
been suggested that parallel G-quadruplexes could be responsible
for the correct alignment of the four chromatids52. The ability
of telomerase to partially unwind and extend parallel
G-quadruplexes potentially formed during meiosis may be
necessary for the maintenance of germline telomere length.
Alternatively, G-quadruplexes may be involved in the association
of telomeres of sister chromatids during S phase, which is
known to be necessary for telomerase to lengthen telomeres in
human cells53. The data presented here provide evidence that
subtypes of telomeric G-quadruplexes interact differentially
with human telomerase, possibly reflecting their different
biological roles.
Methods
Oligonucleotide preparation. DNA oligonucleotides (Table 1) were purchased
from Sigma Genosys in desalted form. All oligonucleotides were purified by
electrophoresis on denaturing 20% polyacrylamide/8 M urea gels in 1 TBE buffer
(89 mM Tris, 89 mM borate and 2 mM EDTA). The major band was excised and
eluted by crushing and soaking for 12–16 h at 4 C with rotation in TEK (10 mM
Tris-HCl, pH 7.5–8.0, 1 mM EDTA and 250 mM KCl) for 7GGT and TESr (10 mM
Tris-HCl, pH 7.5–8.0, 1 mM EDTA and 250 mM SrCl2) for 22GGG, and ethanol
precipitated for 2–16 h at  20 C. The precipitated product was resuspended in
10 mM Tris-Cl, pH 7.5.
G-quadruplex formation and purification. 7GGT (1 mM) or 22GGG (700 mM)
were heat denatured in Kþ hTel buffer (50 mM Tris-HCl, pH 8.0, 1 mM MgCl2
and 150 mM KCl) or Sr2þ hTel buffer (50 mM Tris-HCl, pH 8.0, 1 mM MgCl2 and
2.5 mM SrCl2), respectively, for 5 min at 95 C. They were allowed to cool slowly
(B1 h) to 25 C and left to equilibrate at this temperature for 72 h. The folded
DNA was added to 6 native gel loading buffer (0.25% bromophenol blue, 0.25%
xylene cyanol and 30% glycerol). 7GGT was electrophoresed on a non-denaturing
12% polyacrylamide gel containing 150 mM KCl for 4.5 h at 12 W at 22 C. 22GGG
was electrophoresed on a non-denaturing 12% polyacrylamide gel containing
2.5 mM SrCl2 for 24 h at 40 V at 18 C. Both buffer and gel contained the same
constituents as the DNA-folding buffer. Ultraviolet shadowing was used to confirm
the location of the DNA bands on the gel. The band of interest was excised and
crushed in either TEK (7GGT) or TESr (22GGG) and incubated for 2–16 h at 4 C
with rotation. The supernatant was filtered (0.22 mm) and the DNA precipitated
with ethanol for 2–16 h at  20 C. The precipitated product was resuspended in
the original folding buffer. DNA concentrations were determined by ultraviolet
absorbance at 260 nm (7GGT: 69,800 M 1 cm 1; 22GGG: 228,500 M 1 cm 1;
9C: 76,500 M 1 cm 1). Concentrations of G-quadruplexes are given as the
concentration of assembled complexes (that is, taking strand stoichiometry into
account). Folded G-quadruplexes were stored at 4 C until use.
In some experiments, oligonucleotides were 50-end-labelled with [g-32P]ATP
prior to G-quadruplex formation and purification, as described23. Radiolabelled
structures were used for some native gel analyses (for example, Fig. 1a), and P1
digestion assays, at 10–15 103 c.p.m. per gel lane, whereas unlabelled
G-quadruplexes were used for telomerase assays, CD analysis and other native gel
analyses (for example, Fig. 1c). In the latter experiment, 250 ng of each DNA was
electrophoresed on a non-denaturing 12% polyacrylamide gel, which was stained in
1 SYBR Gold (Life Technologies) at 25 C for 30 min, and visualized on a
Typhoon FLA9500 scanner (GE Healthcare Lifesciences) using a 488-nm laser and
a 526 BP emission filter.
Circular dichroism. CD spectra were recorded at 25 C on a Jasco J-810 spectro-
meter or an Aviv 215S CD spectrometer equipped with a Peltier temperature
controller. G-quadruplex samples of the desired conformation were prepared at
20mM in corresponding hTel buffers. Four scans were accumulated over the
wavelength range 220–320 nm in a 0.1-cm pathlength cell at standard sensitivity,
data pitch 0.1 nm, continuous scanning mode, scanning speed 100 nm min 1,
response 4 s and bandwidth 1 nm. Buffers alone were also scanned and these
spectra subtracted from the average scans for each sample. CD spectra were
collected in units of millidegrees, normalized to the total species concentrations
and expressed as molar ellipticity units (deg cm2 dmol 1).
Electrospray ionization mass spectrometry. All ESI mass spectra were obtained
using a Waters Q-TOF Ultima ESI mass spectrometer (Manchester, UK). Purified
G-quadruplex samples were dissolved in 150 mM NH4OAc at a concentration
of 20mM. In all experiments the capillary voltage (2.2 kV), cone voltage (35 V),
desolvation temperature (40 C), radio frequency lens (65 V), desolvation gas flow
(150 l h 1), collision energy (4 V), cone gas flow (0.0021 l h 1) and TOF (9.1 kV)
remained the same. All spectra were obtained in the negative ion mode. The
instrument was calibrated using 1 mg ml 1 caesium iodide. Samples were injected
at a flow rate of 10ml min 1 with a Harvard Model 22 syringe pump (Natick,
USA).
Complementary C-strand trap assay. This method was carried out using a
modified procedure to that published37,38. 32P-labelled gel-purified [7GGT]4
(3,000 c.p.m. ml 1, 4 mM) or unlabelled [22GGG]2 (2.5 mM) were incubated in the
presence of a 10-fold excess of 9C (Table 1) at 30 C to give a final reaction volume
of 28 ml. Aliquots (4ml) of this hybridization reaction were removed at regular time
intervals and loaded onto a native 12% polyacrylamide gel containing 150 mM
KCl ([7GGT]4) or a native 16% polyacrylamide gel containing 2.5 mM
SrCl2 ([22GGG]2), with the gel running continuously between time points.
Electrophoresis was conducted as described above. For complementary C-strand
trap assays with increasing 9C concentrations, 32P-labelled gel-purified [7GGT]4
was incubated at 11mM in the presence of a 5-, 10-, 25- or 100-fold excess of 9C at
either 30 C or 37 C. For [7GGT]4, the gel was dried at 80 C for 40 min, exposed
to a PhosphorImager screen, visualized on a Typhoon FLA9500 scanner and
analysed using ImageQuant software. For [22GGG]2, the gel was stained with
SYBR Gold at 25 C for 30 min, visualized on a Typhoon FLA9500 scanner and
analysed using ImageQuant software. Uncropped versions of blots are provided in
Supplementary Fig. 7.
Phosphodiesterase 1 digestion of G-quadruplexes. 32P-end-labelled [7GGT]4 or
[22GGG]2 (15,000 c.p.m.) and their linear controls were incubated with 2 mg P1
(Affymetrix; resuspended in 110 mM Tris-HCl, pH 8.9, 110 mM NaCl, 15 mM
MgCl2 and 50% glycerol) in hTel buffer (as listed above) for 1 h at 30 C in a total
reaction volume of 20 ml. The reaction was terminated with 80 ml of stop-buffer
(50 mM Tris-HCl, pH 8.3, 20 mM EDTA, 0.2% SDS and 1–2 103 c.p.m. of a
50-32P-labelled synthetic 100-mer DNA as an internal recovery standard). From
this point, the samples were treated in the same manner as ‘telomerase activity
assay’ reactions (see below).
HEK293T fermentation and telomerase overexpression. HEK293T cells
(from Dr Timothy Adams, Commonwealth Scientific and Industrial Research
Organisation) were adapted to grow in suspension in Freestyle 293 Expression
medium (Life Technologies) supplemented with 200 mg l 1 G418 (Life
Technologies) using a humidified shaker incubator (37 C, 5% CO2, 130 r.p.m.).
The adapted HEK293T culture was maintained in Erlenmeyer shaker flasks and
scaled up in a 20-l WAVE bioreactor (GE Healthcare), seeded at an initial working
volume of 5 l at a concentration of 0.8 106 viable cells per ml. To reduce shear
stress, Pluronic F86 (Life Technologies) was added to the culture at 0.2% w/v final
concentration. The culture was scaled up to 20 l at a viable cell density of 3 106
cells per ml, at which time transient transfection was initiated. The hTERT gene54
under a CMV promoter was cloned into plasmid pAPEX-3P40,55. The hTR gene
under a U3 promoter56 and dyskerin (OriGene Technologies) under a CMV
promoter were cloned into a single plasmid in vector pAPEX-3 (ref. 55). Plasmids
were produced on the 200-mg scale by GenScript (USA) and used at an
hTERT:hTR ratio of 1:19 by weight. Polyethylenimine (25 kDa linear, Polysciences)
was prepared as an aqueous solution at 1 mg ml 1 at pH 7.0 and filter-sterilized
(0.22 mm). Per litre of culture, a transfection mix was prepared by adding 1 mg
DNA to 100 ml PBS pre-warmed to 37 C, followed by addition of 4 ml
polyethylenimine solution; the solution was mixed gently and incubated at room
temperature (RT) for 15 min prior to addition to the 20-l culture, which was
maintained at 37 C with a rocking speed of 25 r.p.m. and rocking angle of 9.
At 2 days after transfection, the culture was fed with 5 g l 1 Lupin (Cell
Biosciences), 2 mM Glutamax-1 (Life Technologies) and 5 g l 1 glucose (Sigma),
and the temperature was reduced to 32 C. The cells were harvested 4 days after
transfection by centrifugation (1,500g, 10 min, 4 C), snap-frozen on liquid
nitrogen and stored at  80 C. Telomerase high-expressing HEK293T cell pellets
are available from Abbexa Ltd, Cambridge, UK.
Purification of overexpressed 293T telomerase. Approximately 130 g 293T cell
mass (B4 1010 cells) was broken up to a paste in a 1-l plastic beaker. The cell
paste was suspended in 800 ml ice-cold lysis buffer (10 mM HEPES-KOH (pH 8.0),
20 mM KCl, 2 mM MgCl2, 1% v/v Triton X-100, 1 mM dithiothreitol (DTT)). Once
suspended, 8 ml of phenylmethylsulfonyl fluoride solution (100 mM in ethanol,
made fresh) was added with stirring. The suspension was transferred in 50-ml
portions to a 50-ml Dounce homogenizer with a tight pestal on ice and processed
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to ensure complete dissolution of cell paste, then pooled into a 1-l bottle equipped
with magnetic stir bar. The lysate was stirred on ice for 1 h, then divided between
four 250-ml bottles for the Beckman JA-14 rotor. The lysate was clarified with
centrifugation at 14,000 r.p.m. (B30,000g) at 2 C for 30 min. The clear lysate
(B850 ml) was collected into a 1-l bottle equipped with magnetic stirrer. With
stirring on ice, 22 ml of 2 M MgCl2 (B50 mM final Mg2þ ) was added and the
suspension was stirred for 1 h to selectively precipitate ribonucleoprotein com-
plexes57. The suspension was divided between four 250-ml bottles for the Beckman
JA-14 rotor, and the products were collected with centrifugation at 10,000 r.p.m.
(B15,000g) at 2 C for 30 min. The supernatant was decanted to provide white
pellets. Each pellet was suspended in 50 ml immunoprecipitation (IP) buffer
(50 mM HEPES-KOH (pH 8.0), 500 mM KCl, 2 mM MgCl2, 1% v/v Triton X-100,
10% v/v glycerol and 1 mM DTT). To aid dissolution, the suspension was
processed through a Dounce homogenizer with a tight pestal on ice until a slightly
white, homogeneous solution was obtained. The material was pooled into a 500-ml
bottle on ice, and the volume was made up to 300 ml with additional IP buffer.
Polyclonal hTERT antibody (raised against hTERT amino acids 276–294
(ARPAEEATSLEGALSGTRH)41; available from Abbexa Ltd) (12 mg¼ 40mg ml 1
final concentration) was added and the solution shaken on ice for 30 min. To
capture the antibody–telomerase complex, 12 ml of a 50% v/v slurry of Protein
G/sepharose (GE Healthcare) was added (20 ml beads per ml final concentration)
and the suspension was shaken on ice for 1.5 h. Working in a cold room, the
immunoprecipitate was collected into a 50-mm diameter fritted glass column
(Bio-Rad) with vacuum suction and then washed with 200 ml ice-cold IP buffer.
The immunoprecipitate was suspended in 20 ml telomerase buffer (50 mM HEPES-
KOH (pH 8.0), 300 mM KCl, 2 mM MgCl2, 0.1% v/v Triton X-100, 10% v/v
glycerol and 1 mM DTT) containing 3 mg peptide ARPAEEATSLEGALSGTRH
(20 molar equiv per antibody, available from Abbexa Ltd). The suspension was
incubated at RT for 1 h with gentle shaking every 5 min, then the eluate was either
collected (for use in assays requiring immunopurified telomerase) or transferred
directly to a 25-mm diameter fritted glass column (Bio-Rad) containing 15 nmol
gel-purified 50-BIOTIN-CTAGACCTGTCATCA(TTAGGG)3-30 oligonucleotide
immobilized on 500 ml UltraLink Neutravidin Plus beads (Thermo-Fisher) (for the
highly purified preparations in Figs 3d and 4b). The suspension was rotated at RT
for 30 min and then at 4 C for 1 h. For the work in this paper, it was necessary to
elute telomerase in the presence of two different solution-phase DNA ‘traps’,
so that this DNA (traces of which remain in the purified telomerase preparation)
was identical to the substrates being tested: 6 ml of suspension was collected in each
of two 0.5-ml micro-spin columns (GE Healthcare), and washed with 3 ml cold
telomerase buffer. After washing, columns were centrifuged for 10 s at 2,400 g to
remove residual buffer. Each bead sample was suspended in 500 ml telomerase
buffer, followed by addition of 25 nmol of one of two different solution-phase
DNAs dissolved in 100 ml telomerase buffer: (i) 7GGT (Table 1) or (ii) [7GGT]4
G-quadruplex. Activity-dependent elution was initiated by addition of 6 ml
dTTPþ dATP (10 mM each deoxyribonucleotide triphosphate, final concentration
0.1 mM). The suspensions were rotated at RT for 30 min and the product solutions
collected with centrifugation at 2,400g for 10 s. Each product solution was layered
on an 11-ml 10-40% glycerol gradient composed of (20 mM HEPES-KOH
(pH 8.0), 300 mM KCl, 2 mM MgCl2, 0.1% w/v octyl b-D-glucopyranoside and
1 mM DTT) in Beckman Ultra-clear centrifuge tubes (14 89 mm) for the
Beckman SW-41 rotor. Telomerase was sedimented with centrifugation at
35,000 r.p.m. (B210,000g at rmax) at 4 C for 20 h. The tube was punctured at the
bottom with a 30-gauge needle, and 0.5-ml fractions were collected by gravity.
Fractions were assayed for telomerase concentration by dot-blot northern against
hTR as described40, and equal amounts of enzyme used in each assay. Telomerase
typically eluted in fractions 7–9; B3–5 pmol telomerase was obtained from each
gradient. For extension assays using linear 7GGT or [7GGT]4 as substrates
(Fig. 3d), the enzyme prepared in the presence of the equivalent ‘trap’ DNA was
used (with the [7GGT]4-trapped enzyme being used for the ‘No DNA’ lanes).
Enzyme trapped with linear 7GGT was dialysed into telomerase buffer containing
2.5 mM SrCl2, and equal amounts of this enzyme used for the extension of 22GGG
and [22GGG]2 in Fig. 4b.
SDS–PAGE and silver-staining analysis of purified telomerase. A 50-ml aliquot
of purified telomerase, eluted in the presence of [7GGT]4 G-quadruplex DNA, was
placed in a Pierce Slide-a-Lyzer mini-dialysis cup (MWCO 3,500) and dialysed at
RT for 30 min against 200 ml of (20 mM HEPES-KOH (pH 8.0), 20 mM KCl, 2 mM
MgCl2, 20% v/v glycerol, 0.1% w/v octyl b-D-glucopyranoside and 1 mM DTT).
For SDS–PAGE, 30 ml of the dialysed solution was combined with 10 ml 10% w/v
SDS, 5 ml 1 M DTT and 5 ml 4 NuPAGE LDS loading buffer (Life Technologies).
The sample was denatured at 80 C for 10 min, cooled to RT and centrifuged at
16,000g for 1 min. A 20-ml aliquot was electrophoresed over a NuPAGE 4–12%
bis-Tris gradient mini-gel at 100 V for 3 h. For the molecular weight marker, the
Life Technologies Benchmark protein ladder was diluted 100-fold in 1 NuPAGE
LDS loading buffer; from this, 3 ml was diluted with 20ml 1 LDS buffer and
loaded on the gel. Silver staining was performed with the Life Technologies
SilverXpress kit.
DHX36 western blotting. A 25-ml aliquot of immunopurified telomerase or
four-step purified telomerase, eluted in the presence of [7GGT]4 G-quadruplex
DNA, was combined with: 20 ml H2O, 25ml 4 NuPAGE LDS loading buffer, 10 ml
1 M DTT and 20 ml 10% w/v SDS. The samples were denatured at 80 C for 10 min,
cooled to RT and centrifuged at 16,000g for 1 min. A 30-ml aliquot of each was
electrophoresed over a NuPAGE 4–12% bis-Tris gradient mini-gel at 100 V for 4 h.
For the molecular weight marker, 2 ml of the Life Technologies MagicMark-XP was
used. Proteins were transferred to polyvinylidene difluoride membranes at 30 V for
90 min. Blocking, washing, secondary anti-rabbit and chemiluminescent detection
were performed using the Western Breeze reagents from Life Technologies. The
primary anti-DHX36 antibody was polyclonal from rabbit, Abcam #70269, diluted
1:500 in primary antibody diluent; probing was performed at RT for 2 h. Figure 3c
represents a 10-min exposure.
Dyskerin western blotting. HEK293T cell pellets were resuspended in
4 NuPAGE LDS loading buffer, 2% b-mercaptoethanol and 2% Benzonase
nuclease (Merck Millipore) at 10,000 cells per ml. The samples were denatured at
68 C for 10 min and centrifuged at 16,000g for 1 min. A 5-ml aliquot of each was
electrophoresed over a NuPAGE 4–12% bis-Tris gradient mini-gel at 100 V for 2 h.
For the molecular weight marker, 5 ml of the Bio-Rad Preision Plus prestained
marker was used. Proteins were transferred to nitrocellulose membrane at 100 V
for 60 min. Membranes were blocked using 5% skim milk, probed with primary
antibodies diluted in 1% skim milk (mouse monoclonal anti-vinculin 1:5,000
(Sigma #V9131) or polyclonal rabbit anti-dyskerin (in-house) 1:1,000) for 1 h at RT
and washed 5 5 min in TBST (0.24% Tris-Cl, 0.05% Tris, 0.8% NaCl and 0.1%
Tween-20, pH 7.6). Membranes were then probed with horseradish peroxidase-
conjugated secondary antibodies (goat anti-mouse or goat anti-rabbit; DAKO)
diluted 1:5,000 in 1% milk. Detection was performed with Amersham ECL Prime
western blotting detection reagent and a FujiFilm Las4000 luminescent image
analyzer, with autoexposure.
Telomerase activity assays. The following reaction was prepared to give 15 ml per
sample: between 1 nM and 2 mM of the specified oligonucleotide, 50 mM Tris-HCl
pH 8.5, 1 mM MgCl2, 5 mM DTT, 1 mM spermidine-HCl, 0.5 mM dTTP, 0.5 mM
dATP, 4.6 mM non-radioactive dGTP and 0.33 mM [a-32P]dGTP at 20 mCi ml 1,
6,000 Ci mmol 1 (PerkinElmer Life Sciences), 10% glycerol and either 150 mM
KCl for experiments with 7GGT or 2.5 mM SrCl2 for experiments with 22GGG.
The reaction was initiated by adding 5 ml of purified human telomerase, and
incubating at 30 C for 1 h. The reaction was quenched by the addition of 80 ml
of stop-buffer (50 mM Tris-HCl, pH 8.3, 20 mM EDTA and 0.2% SDS) and
1–2 103 c.p.m. of a 50-32P-labelled synthetic 100-mer DNA as an internal
recovery standard. The solution was extracted with an equal volume of phenol/
chloroform/isoamyl alcohol (25:24:1, v/v/v) and precipitated with ethanol in the
presence of 2.5 M NH4OAc. The pellet was air-dried at RT for 15 min and dissolved
in 5 ml TE buffer (10 mM Tris-HCl, pH 8.0 and 1 mM EDTA, pH 8.0), followed by
addition of 5 ml formamide buffer (90% deionized formamide, 0.1% bromophenol
blue and 0.1% xylene cyanol in 1TBE). The solution was heated at 90 C for
5 min, and 3 ml was electrophoresed over a 10% polyacrylamide sequencing gel
(0.2 mm thick 40 cm length 35 cm width, 32-well comb) run in 1TBE/8 M
urea at 85 W. The gel was transferred to filter paper, dried for 30 min at 80 C,
exposed to a PhosphorImager screen, visualized on a Typhoon FLA9500 scanner
(GE Healthcare Lifesciences) and analysed using ImageQuant software. The total
intensities of extension products were normalized against the intensity of the
32P-labelled 100-mer recovery and loading control. Resulting values were expressed
as a percentage of the reaction with maximal activity and plotted against substrate
concentrations and fitted to the Michaelis–Menten equation to give Km values.
For experiments where dTTP was titrated, the oligonucleotide concentration
was kept at 1 mM and the concentration of dTTP was changed as outlined in the
figure legend. All other reagents and procedures remained the same. Activity assays
testing templated addition included 1–2 mM of the specified oligonucleotide and
the following combinations and concentrations of labelled and unlabelled
nucleotides; all other reaction conditions remained the same.
7GGT: T,A lanes: 32P-dTTP (25 mM, 80 Ci mmol 1) and dATP (0.5 mM).
T,A,ddG lanes: 32P-dTTP (25mM, 80 Ci mmol 1), dATP (0.5 mM) and ddGTP
(0.5 mM).
T,A,G lanes: 32P-dTTP (25 mM, 80 Ci mmol 1), dATP (0.5 mM) and
dGTP (0.5 mM) or dTTP (0.5 mM), dATP (0.5 mM) and 32P-dGTP (5 mM,
400 Ci mmol 1).
22GGG:T,A lanes: 32P-dTTP (3 mM, 150 Ci mmol 1) and ddATP (25 mM).
T,A,ddG lanes: 32P-dTTP (3 mM, 160 Ci mmol 1), dATP (0.5 mM) and
ddGTP (25 mM).
T,A,G lanes: dTTP (0.5 mM), dATP (0.5 mM) and 32P-dGTP (5 mM,
400 Ci mmol 1).
Experiments in which reaction products were subjected to native gel
electrophoresis contained 2 mM DNA, 0.7 mM non-radioactive dTTP and 0.33 mM
[a-32P]dTTP at 10 mCi ml 1, 3,000 Ci mmol 1, with all other reaction conditions
remaining the same. The reaction was quenched by the addition of 20 ml of
stop-buffer (see above) and 8 103 c.p.m. of a 50-32P-labelled synthetic 100-mer
DNA as an internal recovery standard. The product was purified of unincorporated
deoxyribonucleotide triphosphates using two rounds of mini Quick Spin Oligo
column purification (Roche). Prior to use, Quick Spin Oligo columns were
equilibrated by centrifugation twice at 1,000g for 10 min with 400ml Sr2þ hTel
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8643
10 NATURE COMMUNICATIONS | 6:7643 | DOI: 10.1038/ncomms8643 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
buffer (see above). The purified product was added to 6 native gel loading buffer
(see above) and electrophoresed on a non-denaturing 16% polyacrylamide gel
containing 2.5 mM SrCl2 for B48 h at 40 V at 18 C. Both buffer and gel contained
the same constituents as the DNA-folding buffer. The gel was transferred to filter
paper, dried for 30 min at 80 C, exposed to a PhosphorImager screen, visualized
on a Typhoon FLA9500 scanner and analysed using ImageQuant software.
Expression and purification of G-quadruplex antibody (BG4). BG4-encoding
plasmid (from the laboratory of Professor Shankar Balasubramanian, University of
Cambridge, UK) was transformed into BL21(DE3) competent cells (Stratagene),
which were cultured in TY media (1.6% tryptone peptone, 1% yeast extract and
0.5% NaCl) and 50mg ml 1 kanamycin. BG4 antibody expression was induced
with 0.5 mM isopropyl b-D-1-thiogalactopyranoside for 3 h at 37 C. The cells were
lysed in TES buffer (50 mM Tris-Cl pH 8.0, 1 mM EDTA and 20% sucrose) on ice
for 10 min, diluted twofold in water, and left on ice for a further 10 min prior to
centrifugation at 10,000g at 4 C for 30 min. The supernatant was filtered (0.2 mm)
and purified on a HIS-Select Nickel Affinity column (Sigma). The column was
washed in 10 mM imidazole pH 8.0 in PBS, and BG4 antibody eluted in 250 mM
imidazole pH 8.0 in PBS. BG4 antibody was concentrated and buffer exchanged
into PBS in an Amicon Ultra-15 Centrifugal Filter Unit (Millipore). The con-
centration of BG4 was determined using Thermo Scientific Pierce BCA Protein
Assay kit, and the antibody was stored at  20 C.
Cell synchronization and short interfering RNA (siRNA) transfection.
HEK293T mid-S-phase cell synchronization was performed using cells released
from a thymidine/aphidicolin block as previously described49. Dyskerin
knockdown was performed by reverse transfecting 120 pmol of Invitrogen
custom-designed Stealth siRNA targeting either the dyskerin 30 untranslated region
(siDKC#1, 50-AAGGCCACUUGAAGCUGGAGGAGAA-30) or the coding region
(siDKC#2, 50-GGCCAAGATTATGCTTCCAGGTGTT-30). Cells were transfected
using Life Technologies Lipofectamine RNAiMAX Transfection Reagent. Qiagen
All Stars negative-control siRNA was used as a siRNA control.
Immunofluorescence and telomere/telomerase FISH. Immunofluorescence and
FISH for telomeres and telomerase RNA (hTR) were performed as described49,
with the following modifications. Cytoplasm was removed by incubating slides in
cytoplasmic extraction buffer (20 mM HEPES-KOH, pH 7.9, 20 mM NaCl, 5 mM
MgCl2, 300 mM sucrose and 0.5% (v/v) NP-40) for 10 min with no shaking. Slides
were washed once with PBSþ 0.1% Tween-20, once with PBS and then fixed in 2%
paraformaldehyde in PBS for 20 min. Cells were washed with PBS then incubated
in 0.1% Triton X-100 in PBS for 10 min, followed by rinsing twice in PBS. Slides
were ethanol dehydrated with 70% (2 min), 90% (2 min) and 100% ethanol (2 min)
followed by air drying prior to overlaying with 30 ml of FISH buffer containing 5 ng
each of five Alexa Fluor 488-labelled anti-hTR oligonucleotides and 5 ng of Texas
Red-labelled telomere probe49. Slides were heated to 80 C for 3 min and incubated
in a humidified chamber overnight at 37 C and washed49. Slides were refixed in
2% paraformaldehyde in PBS, washed as before and overlaid with phosphate-
buffered gelatin49 for 1 h. Slides were incubated with BG4 primary antibody
(600 nM) for 1 h at 37 C, washed four times for 5 min with PBSþ 0.01% Tween-20
and then overlaid with secondary antibody (Rabbit anti-DYKDDDDK Tag
Antibody, Cell Signalling; 1:800 dilution) for 1 h at 37 C. Cells were washed as
before and a fluorescently labelled tertiary antibody (Alexa Fluor 647 Donkey
Anti-Rabbit IgG (Hþ L) Antibody, Life Technologies; 1:1,000 dilution) was
overlaid at 37 C for 30 min, washed as before and counterstained with
40 ,6-diamidino-2-phenylindole. Staining was visualized at RT on a Zeiss Axio
Imager M1 microscope, with a Plan-Apochromat  63 oil objective (numerical
aperture, 1.4), and an AxioCam MR digital camera (Carl Zeiss) with consistent
exposure times between experiments. For presentation purposes, pixel intensity
histograms were adjusted in Axiovision (Carl Zeiss), equally across all figure panels,
and images were cropped in Adobe Photoshop.
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